[1]
M. Chmielewski, M. Kuch, and P. Piątkiewicz, “Telmisartan in hypertension coexisting with diabetes or dyslipidaemia – patients’ selection”, J EBM, vol. 10, no. 1(34), pp. 30-33, Mar. 2017.